IDENTIFIKASI POTENTIALLY INAPPROPRIATE MEDICATION (PIM’s) MENGGUNAKAN KRITERIA STOPP PADA PASIEN GERIATRI RAWAT JALAN
DOI:
https://doi.org/10.56711/jifa.v18i1.1479Kata Kunci:
Geriatrics, Potentially Inappropriate Medications, STOPPAbstrak
Potentially Inappropriate Medication (PIM) pada pasien geriatri perlu diidentifikasi karena dapat meningkatkan risiko efek obat yang tidak diinginkan, terutama pada pasien dengan penyakit kronis dan polifarmasi. Saat ini penelitian PIM dengan STOPP 2023 di rawat jalan masih terbatas. Penelitian ini bertujuan untuk mengidentifikasi prevalensi dan pola PIM berdasarkan kriteria STOPP 2023 pada resep pasien geriatri rawat jalan di Rumah Sakit Umum Universitas Muhammadiyah Malang. Penelitian ini merupakan penelitian observasional deskriptif dengan pendekatan retrospektif menggunakan data resep dan rekam medis pasien geriatri rawat jalan pada periode 1-31 Desember 2024. Sampel diperoleh dengan teknik total sampling, dengan unit analisis berupa resep pasien geriatri berusia ≥65 tahun dari poliklinik paru, kardiologi, penyakit dalam, dan neurologi. Sebanyak 1.308 resep dianalisis, dan PIM ditemukan pada 246 resep dengan prevalensi sebesar 18,8%. Resep dengan PIM lebih banyak ditemukan pada resep dengan polifarmasi, serta terutama berasal dari poliklinik kardiologi dan penyakit dalam. Berdasarkan kategori STOPP 2023, PIM paling banyak berkaitan dengan sistem kardiovaskular dan endokrin, dengan obat yang sering teridentifikasi antara lain bisoprolol, digoksin, dan glimepiride sesuai kondisi klinis yang memenuhi kriteria STOPP 2023
Referensi
Direktorat Statistik Kesejahteraan Rakyat. Statistik Penduduk Lanjut Usia. Jakarta: Badan Pusat Statistik. 2004
Shi S, Klotz U. Age-Related Changes in Pharmacokinetics. Curr Drug Metab. 2011; 12(7):601–610
Salive ME. Multimorbidity in Older Adults. Epidemiol Rev. 2013; 35(1):75–83
Bhagavathula AS, Gebreyohannes EA, Fialova D. Prevalence of Polypharmacy and Risks of Potentially Inappropriate Medication Use in the Older Population in a Developing Country: A Systematic Review and Meta-Analysis. Gerontology. 2022; 68(2):136–145
O’Mahony D et al. STOPP/START Criteria for Potentially Inappropriate Prescribing in Older People: Version 3. Eur Geriatr Med. 2023; 14(4):625–632
Jordan Samuel M. American Geriatrics Society 2023 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2023; 71(7):2052–2081
Blanco-Reina E et al. Assessing Potentially Inappropriate Prescribing in Community-Dwelling Older Patients Using the Updated Version of STOPP-START Criteria: A Comparison of Profiles and Prevalences with Respect to the Original Version. PLoS One. 2016; 11(12):e0167586
Al-Busaidi S et al. Potentially Inappropriate Prescribing among Elderly Patients at a Primary Care Clinic in Oman. J Cross Cult Gerontol. 2020; 35(2):209–216
Wannawichate T, Manjavong M, Limpawattana P. Exploring Potentially Inappropriate Medications for Elderly Thai Patients in an Outpatient Setting at a Tertiary Care Hospital: An Analysis Based on the 2023 American Geriatrics Society Beers Criteria. Journal of the Medical Association of Thailand. 2024; 107(Suppl. 1):1–8
Viviandhari D, Nurhasnah N, Sakinah RN, Wulandari D. A Comparison of Potentially Inappropriate Medications Identification Using Beers and STOPP Criteria in Hospitalized Geriatric Patients in Jakarta. Indonesian Journal of Clinical Pharmacy. 2022; 11(2):105–115
Pebriani M et al. Potentially Inappropriate Medication (PIM) Prescribing According to Beers Criteria among Elderly Outpatients at Pasar Minggu Hospital, Jakarta. Jurnal Kefarmasian Indonesia.; 14(1), URL: https://jkefarind.com/index.php/jki/article/view/6632. (2024, accessed 12 June 2026)
Putra IWRW, Prasetya AANPR, Ratnasari PMD. Identifikasi Potentially Inappropriate Medication Pasien Geriatri Dengan Beers Criteria 2023 Dan STOPP Criteria Version 3. Jurnal Mandala Pharmacon Indonesia. 2024; 10(1):238–249
Rahma S. Profil Penyakit Kronis Pasien Lanjut Usia Yang Berobat Di Poli Geriatri Instalasi Rawat Jalan RSUD Dr. Soetomo Surabaya Tahun 2016. Skripsi. Surabaya: Universitas Airlangga. 2018
Weng M-C et al. The Impact of Number of Drugs Prescribed on the Risk of Potentially Inappropriate Medication among Outpatient Older Adults with Chronic Diseases. QJM: An International Journal of Medicine. 2013; 106(11):1009–1015
Szoszkiewicz M et al. Potentially Inappropriate Prescribing Identified Using STOPP/START Version 3 in Geriatric Patients and Comparison with Version 2: A Cross-Sectional Study. J Clin Med. 2024; 13(20):6043
Subeesh VK, Gouri N, Beulah ET, Shivashankar V. A Prospective Observational Study on Polypharmacy in Geriatrics at A Private Corporate Hospital. J Appl Pharm Sci. 2017; 7(10):162–167
Gutiérrez‐Valencia M et al. Impact of Hospitalization in an Acute Geriatric Unit on Polypharmacy and Potentially Inappropriate Prescriptions: A Retrospective Study. Geriatr Gerontol Int. 2017; 17(12):2354–2360
Chen Q, Zhang L. Analysis of Potentially Inappropriate Medications (PIM) Used in Elderly Outpatients in Departments of Internal Medicine by Using the Screening Tool of Older Persons’ Potentially Inappropriate Prescriptions (STOPP) Criteria. Ann Palliat Med. 2021; 10(4):4678–4686
Tian F et al. Prevalence of Use of Potentially Inappropriate Medications Among Older Adults Worldwide. JAMA Netw Open. 2023; 6(8):e2326910
Mathur A, Shah PC. Potentially Inappropriate Prescribing in Elderly: A Comparison of Beers and STOPP Criteria in Tertiary Care. Int J Basic Clin Pharmacol. 2018; 8(1):95
Perpétuo C et al. Prescription of Potentially Inappropriate Medication in Older Inpatients of an Internal Medicine Ward: Concordance and Overlap Among the EU(7)-PIM List and Beers and STOPP Criteria. Front Pharmacol. 2021; 12:676020
Al Khaja KAJ, Ahmed Isa H, Veeramuthu S, Sequeira RP. Potentially Inappropriate Prescribing in Older Adults with Hypertension or Diabetes Mellitus and Hypertension in a Primary Care Setting in Bahrain. Medical Principles and Practice. 2018; 27(3):241–249
Currie GM, Wheat JM, Kiat H. Pharmacokinetic Considerations for Digoxin in Older People. Open Cardiovasc Med J. 2011; 5(1):130–135
Ali A B, Nada F Alrashidi. Bisoprolol. In: StatPearls [Internet]. StatPearls Publishing, pp. 1–5
